Psychedelics diverges from marijuana’s blueprint
Added on 23 February 2024
While most states moved to regulate commercial medical marijuana programs without an extensive library of research, psychedelics advocates are adopting a different strategy.
Photo by Farzan Lelinwalla on Unsplash
More news